A personalized medicine approach is being taken for the treatment of diseases such as cystic fibrosis [92] and cancer [93], and in the future, therapeutic strategies to minimize the impact of hCASK mutations on a developing individual might be tailored to the implicated mutation type, either structural or functional. The gene discussed is CASK; the disease is cancer.